MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII Implementierungsleitfaden Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht - Downloaded Version 2027.0.0-ballot.1 See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="mii-exa-befund-bundle-befund-fgfr2-fusion"/>
<language value="de"/>
<type value="transaction"/>
<timestamp value="2022-12-16T13:47:00+01:00"/>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion"/>
<resource>
<Patient>
<id value="mii-exa-molgen-patient-fgfr2-fusion"/>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<identifier>
<use value="usual"/>
<type>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/v3-ObservationValue"/>
<code value="PSEUDED"/>
</coding>
</type>
<system value="https://www.charite.de/fhir/sid/pseudonym"/>
<value value="3337167192"/>
</identifier>
<gender value="female"/>
<birthDate value="1964-05"/>
<deceasedBoolean value="false"/>
<address>
<type value="both"/>
<postalCode value="10"/>
<country value="DE"/>
</address>
</Patient>
</resource>
<request>
<method value="PUT"/>
<url value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab"/>
<resource>
<Practitioner>
<id value="mii-exa-molgen-practitioner-lab"/>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<active value="true"/>
<name>
<use value="official"/>
<text value="Dr. Daniel Schmidt"/>
<family value="Schmidt"/>
<given value="Daniel"/>
<prefix value="Dr."/>
</name>
</Practitioner>
</resource>
<request>
<method value="PUT"/>
<url value="Practitioner/mii-exa-molgen-practitioner-lab"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician"/>
<resource>
<Practitioner>
<id value="mii-exa-molgen-practitioner-physician"/>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<active value="true"/>
<name>
<use value="official"/>
<text value="Dr. Linda Rubens"/>
<family value="Rubens"/>
<given value="Linda"/>
<prefix value="Dr."/>
</name>
</Practitioner>
</resource>
<request>
<method value="PUT"/>
<url value="Practitioner/mii-exa-molgen-practitioner-physician"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-befundbericht-fgfr2-fusion"/>
<resource>
<DiagnosticReport>
<id value="mii-exa-molgen-befundbericht-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/molekulargenetischer-befundbericht|2027.0.0-ballot.1"/>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report|3.0.0"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<extension
url="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action">
<valueReference>🔗
<reference
value="Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
</valueReference>
</extension>
<basedOn>🔗
<reference
value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
</basedOn>
<status value="final"/>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="GE"/>
<display value="Genetics"/>
</coding>
</category>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="51969-4"/>
<display value="Genetic analysis report"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</subject>
<performer>🔗
<reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
</performer>
<result>🔗
<reference
value="Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
</result>
<result>🔗
<reference
value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
</result>
<result>🔗
<reference
value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
</result>
<conclusion
value="Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie."/>
</DiagnosticReport>
</resource>
<request>
<method value="PUT"/>
<url
value="DiagnosticReport/mii-exa-molgen-befundbericht-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion"/>
<resource>
<ServiceRequest>
<id value="mii-exa-molgen-anforderung-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2027.0.0-ballot.1"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<identifier>
<system value="https://www.charite.de/fhir/auftragsnummern"/>
<value value="PRK4QE59A"/>
</identifier>
<status value="active"/>
<intent value="order"/>
<category>
<coding>
<system value="http://snomed.info/sct"/>
<code value="108252007"/>
<display value="Laboratory procedure (procedure)"/>
</coding>
</category>
<code>
<coding>
<system value="http://snomed.info/sct"/>
<code value="405825005"/>
<display value="Molecular genetic test (procedure)"/>
</coding>
<text
value="Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"/>
</code>
<subject>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</subject>
<authoredOn value="2022-11-30"/>
<requester>🔗
<reference
value="Practitioner/mii-exa-molgen-practitioner-physician"/>
</requester>
<reasonCode>
<coding>
<system value="http://snomed.info/sct"/>
<code value="109842005"/>
<display value="Intrahepatic bile duct carcinoma (disorder)"/>
</coding>
<coding>
<system value="http://fhir.de/CodeSystem/bfarm/icd-10-gm"/>
<version value="2024"/>
<code value="C22.1"/>
<display value="Intrahepatisches Gallengangskarzinom"/>
</coding>
</reasonCode>
</ServiceRequest>
</resource>
<request>
<method value="PUT"/>
<url value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion"/>
<resource>
<Observation>
<id value="mii-exa-molgen-variante-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/variante|2027.0.0-ballot.1"/>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant|3.0.0"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<basedOn>🔗
<reference
value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
</basedOn>
<status value="final"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/observation-category"/>
<code value="laboratory"/>
<display value="Laboratory"/>
</coding>
</category>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="GE"/>
</coding>
</category>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="69548-6"/>
<display value="Genetic variant assessment"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</subject>
<effectiveDateTime value="2022-11-30"/>
<valueCodeableConcept>
<coding>
<system value="http://loinc.org"/>
<code value="LA9633-4"/>
<display value="Present"/>
</coding>
</valueCodeableConcept>
<method>
<coding>
<system value="http://loinc.org"/>
<code value="LA26398-0"/>
<display value="Sequencing"/>
</coding>
<coding>
<system value="http://loinc.org"/>
<code value="86206-0"/>
<display
value="Whole genome sequence analysis in Blood or Tissue by Molecular genetics method"/>
</coding>
</method>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="48018-6"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://www.genenames.org/geneId"/>
<code value="HGNC:3689"/>
<display value="FGFR2"/>
</coding>
</valueCodeableConcept>
</component>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="48019-4"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://sequenceontology.org"/>
<code value="SO:0001565"/>
<display value="gene_fusion"/>
</coding>
</valueCodeableConcept>
</component>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="95123-6"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://www.genenames.org/geneId"/>
<code value="HGNC:3689::HGNC:2697"/>
<display value="FGFR2::DBP"/>
</coding>
</valueCodeableConcept>
</component>
</Observation>
</resource>
<request>
<method value="PUT"/>
<url value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
<resource>
<Observation>
<id value="mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/diagnostische-implikation|2027.0.0-ballot.1"/>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/diagnostic-implication|3.0.0"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<status value="final"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/observation-category"/>
<code value="laboratory"/>
<display value="Laboratory"/>
</coding>
</category>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="GE"/>
</coding>
</category>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
<code value="diagnostic-implication"/>
<display value="Diagnostic Implication"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</subject>
<effectiveDateTime value="2022-11-30"/>
<performer>🔗
<reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
</performer>
<derivedFrom>🔗
<reference
value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
</derivedFrom>
<component>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
<code value="conclusion-string"/>
</coding>
</code>
<valueString value="starke Überexpression (25-fach)"/>
</component>
</Observation>
</resource>
<request>
<method value="PUT"/>
<url
value="Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
<resource>
<Observation>
<id value="mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation|2027.0.0-ballot.1"/>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication|3.0.0"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<status value="final"/>
<category>
<coding>
<system
value="http://terminology.hl7.org/CodeSystem/observation-category"/>
<code value="laboratory"/>
<display value="Laboratory"/>
</coding>
</category>
<category>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/v2-0074"/>
<code value="GE"/>
</coding>
</category>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
<code value="therapeutic-implication"/>
<display value="Therapeutic Implication"/>
</coding>
</code>
<subject>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</subject>
<effectiveDateTime value="2022-11-30"/>
<performer>🔗
<reference value="Practitioner/mii-exa-molgen-practitioner-lab"/>
</performer>
<derivedFrom>🔗
<reference
value="Observation/mii-exa-molgen-variante-fgfr2-fusion"/>
</derivedFrom>
<component>
<code>
<coding>
<system
value="http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs"/>
<code value="conclusion-string"/>
</coding>
</code>
<valueString
value="Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."/>
</component>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="51963-7"/>
<display value="Medication assessed [ID]"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://www.whocc.no/atc"/>
<code value="L01EN"/>
<display
value="Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"/>
</coding>
<coding>
<system value="http://snomed.info/sct"/>
<code value="1162485005"/>
<display
value="Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"/>
</coding>
</valueCodeableConcept>
</component>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="93044-6"/>
</coding>
</code>
<valueCodeableConcept>
<text value="m1c"/>
</valueCodeableConcept>
</component>
<component>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="81259-4"/>
</coding>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="109842005"/>
<display value="Intrahepatic bile duct carcinoma (disorder)"/>
</coding>
<coding>
<system value="http://fhir.de/CodeSystem/bfarm/icd-10-gm"/>
<version value="2024"/>
<code value="C22.1"/>
<display value="Intrahepatisches Gallengangskarzinom"/>
</coding>
</valueCodeableConcept>
</component>
</Observation>
</resource>
<request>
<method value="PUT"/>
<url
value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
</request>
</entry>
<entry>
<fullUrl
value="https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
<resource>
<Task>
<id value="mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
<meta>
<profile
value="https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2027.0.0-ballot.1"/>
<profile
value="http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"/>
</meta>
<language value="de"/>
<text>
<status value="generated"/>
</text>
<basedOn>🔗
<reference
value="ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"/>
</basedOn>
<status value="requested"/>
<intent value="proposal"/>
<code>
<coding>
<system value="http://loinc.org"/>
<code value="LA26421-0"/>
<display value="Consider alternative medication"/>
</coding>
<text value="Hochselektive FGFR-Inhibitor-Therapie"/>
</code>
<for>🔗
<reference value="Patient/mii-exa-molgen-patient-fgfr2-fusion"/>
</for>
<reasonReference>🔗
<reference
value="Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"/>
</reasonReference>
</Task>
</resource>
<request>
<method value="PUT"/>
<url value="Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"/>
</request>
</entry>
</Bundle>